ArticleJournal of thoracic disease2025
The impact of donor-recipient size mismatch on lung transplant outcomes.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Transforming lung transplantation with artificial intelligence: a narrative review from organ allocation to post-transplant management.Journal of thoracic disease · 2026Review
- Increased Eplet Mismatch Load and Reduced Immunosuppressive Exposure Elevate the Risk of Baseline Lung Allograft Dysfunction.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung transplantation (LT) represents a critical therapeutic intervention for advanced chronic lung diseases. This study aims to elucidate the prognostic implications of donor-recipient size matching, specifically focusing on the ratio of predicted total lung capacity (pTLC). Methods: We conducted a retrospective cohort analysis of 380 transplant recipients at a single LT center from January 2015 to October 2023. Patients were stratified based on size discrepancies exceeding 10% and 20%, calculated using two established formulas. Results: Our findings indicate that significant size mismatches do not correlate with adverse post-transplant outcomes, including primary graft dysfunction (PGD), duration of mechanical ventilation, or overall survival rates. Notably, a size discrepancy greater than 20% utilizing the first formula emerged as an independent risk factor for the composite outcome of chronic lung allograft dysfunction (CLAD) and mortality. While the majority of donor-recipient pairings were of the same sex, sex mismatch significantly influenced size discrepancies. Furthermore, chronic obstructive pulmonary disease (COPD) patients demonstrated elevated pTLC ratios compared to those with interstitial lung disease (ILD), underscoring the complexity inherent in size matching across different pathologies. Conclusions: Our data suggests that significant size discrepancies between donor and recipient do not adversely impact immediate outcomes in LT recipients, but it may have significant long-term implications; therefore, appropriate donor size selection for each recipient is essential. The use of pTLC formulas can be helpful for estimating the suitable size.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.